about
Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted TherapyInnate immune regulation by STAT-mediated transcriptional mechanisms.Current treatment practice in immunosuppression.FLT3: ITDoes matter in leukemia.Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases.Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds.Dendritic cells are abundant in non-lesional gray matter in multiple sclerosisA phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance).Targeting FLT3 to treat leukemia.High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma.Gene expression markers of Tumor Infiltrating Leukocytes.Endurance Exercise Improves Molecular Pathways of Aerobic Metabolism in Patients With Myositis.Bone marrow stromal cells spontaneously produce Flt3-ligand: influence of ionizing radiations and cytokine stimulation.Serum Cytokine Profiling in Cats with Acute Idiopathic Cystitis.The immune-stimulation capacity of liposome-treated red blood cells.Nlrp3-dependent IL-1β inhibits CD103+ dendritic cell differentiation in the gut.
P2860
Q26749870-0D5919CB-A881-42BA-82D1-1670FD11742FQ34055968-8F357AB8-57D9-4935-9AAE-473F12F25F1DQ34181796-A0C2FDF8-104C-4819-962F-7ABC526F22A6Q35217399-0A56D0F6-CAD2-43CB-9233-C6B1D1AD01A8Q35946021-CC468300-F23B-4D3B-8B9E-B42BA3D4D671Q35957698-CE98371F-CA22-4875-A57F-99046642C3DDQ36121764-58AF0FCE-F08A-4DF5-8640-C3FBC15F0140Q37170610-3205CDE6-17C9-4A19-AF78-46CD63179FE3Q38251339-44137189-3DED-4205-A2AF-D9811D0DE59CQ38654361-137C02AC-E4BF-447C-B20B-FE9A802A026BQ38752940-618BD031-8BC7-4B23-9CC8-D3027848D73EQ40004698-7A1383CA-6107-4AAD-82CB-D35537884035Q46496319-1CFB9AD1-E7C6-433F-B420-64594CD55070Q48197487-7E596A7C-801C-434E-91B0-E67DDE02B27AQ50213921-CC07435A-67AF-4A49-A0D2-73CCED10D2A7Q52728109-9BE77F05-E234-408B-87AB-355B91E5CA8D
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Expression of Flt3-ligand by the endothelial cell
@ast
Expression of Flt3-ligand by the endothelial cell
@en
Expression of Flt3-ligand by the endothelial cell
@nl
type
label
Expression of Flt3-ligand by the endothelial cell
@ast
Expression of Flt3-ligand by the endothelial cell
@en
Expression of Flt3-ligand by the endothelial cell
@nl
prefLabel
Expression of Flt3-ligand by the endothelial cell
@ast
Expression of Flt3-ligand by the endothelial cell
@en
Expression of Flt3-ligand by the endothelial cell
@nl
P2093
P3181
P356
P1433
P1476
Expression of Flt3-ligand by the endothelial cell
@en
P2093
A Solanilla
C Lemercier
J Reiffers
K Schweitzer
P2888
P304
P3181
P356
10.1038/SJ.LEU.2401635
P407
P577
2000-01-01T00:00:00Z
P5875
P6179
1010107490